Bill & Melinda Gates Foundation Co-chair Bill Gates, WHO Director-General Margaret Chan and Independent Monitoring Board chairperson Sir Liam Donaldson. BMGF/J.Morgan (Source:Global Polio Eradication Initiative)

This carefully documented article by Margaret Kimberley published on October 5, 2014 sheds light on the history of the Ebola crisis in Africa as well as the ongoing role of the Bill and Melinda Gates Foundation.

The last WHO Report evaluates thecurrent situation (May 2026)as follows::

“On 5 May 2026, the World Health Organization (WHO) was alerted of a high-mortality outbreak of unknown illness in Mongbwalu Health Zone, Ituri Province, Democratic Republic of the Congo (DRC), including deaths among health workers.

On 14 May 2026, the Institut national de recherche biomédicale (INRB) Kinshasa analyzed 13 blood samples from Rwampara Health Zone, Ituri Province. Laboratory analysis confirmed Bundibugyo virus disease (BVD) in eight of these samples on 15 May, a species of Ebola.

The case fatality rates in the past two BVD outbreaks have ranged from 30% to 50%. Unlike Ebola virus disease, there is no licensed vaccine or specific therapeutics against Bundibugyo virus, though early supportive care is lifesaving.”

According to Business Day Nigeria, The Gates Foundation is largely providing support to the AFCDCP and the WHO:

The Bill & Melinda Gates Foundationis unlocking an initial $15 million in emergency funding to help contain a nascent outbreak of the Bundibugyo Ebola virus spreading across the Democratic Republic of Congo and Uganda.

To ensure capital reaches the front lines with maximum velocity, the foundation is dividing the commitment into three equal $5 million tranches. The Africa Centers for Disease Control and Prevention will receive a third of the funds to spearhead regional coordination, rapid deployment, and cross-border surveillance.

Another $5 million is earmarked for the World Health Organization’s regional office for Africa to back frontline operations, while the final tranche will flow to WHO headquarters to finance rapid procurement, surge logistics, and critical diagnostic commodities.

Source: Global Research